What is total bilirubin (Tbili)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Total Bilirubin (TBili)?

Total bilirubin (TBili or TBIL) is a laboratory measurement that represents the sum of both unconjugated (indirect) and conjugated (direct) bilirubin in the blood, serving as a key marker for assessing liver function, biliary excretion, and hemolysis. 1

Biochemical Basis

  • Bilirubin is predominantly the breakdown product of the heme component of hemoglobin processed by the reticuloendothelial system 1

  • Bilirubin exists in two forms:

    • Unconjugated (indirect) bilirubin: insoluble form transported to the liver bound to albumin 1
    • Conjugated (direct) bilirubin: water-soluble form created in the liver by binding with glucuronic acid, allowing excretion 1
  • Total bilirubin comprises both fractions, and elevations of either will increase the measured concentration 1

Clinical Interpretation

Pattern Recognition

  • Unconjugated hyperbilirubinemia typically indicates hemolysis or impaired conjugation (such as Gilbert's syndrome) 1

  • Conjugated hyperbilirubinemia typically reflects parenchymal liver disease or biliary obstruction 1

  • In adults, except during the neonatal period, the majority of measurable bilirubin should be conjugated, even in patients with significant liver disease 1

Gilbert's Syndrome Considerations

  • Gilbert's syndrome, present in up to 10% of the population, is the most common cause of isolated elevated bilirubin 1

  • Gilbert's syndrome can be presumed when conjugated bilirubin is normally less than 30% of total bilirubin in the absence of hemolysis 1

  • When Gilbert's syndrome or hemolysis is present, clinical decision-making should focus on direct bilirubin rather than total bilirubin 1

Clinical Applications

Drug-Induced Liver Injury Monitoring

  • Eligibility screening using TBIL is designed to identify patients with underlying liver pathology who may have increased risk with certain medications 1

  • Elevated direct bilirubin often reflects liver dysfunction that may affect drug metabolism and elimination 1

  • Measurement of both total and direct bilirubin is recommended to distinguish patients with indirect hyperbilirubinemia (Gilbert's syndrome or hemolysis) from true liver injury 1

Neonatal Context

  • In neonates and infants with conjugated bilirubin >25 μmol/L, urgent referral to a pediatrician for assessment of possible liver disease is essential 1

  • Direct-reacting bilirubin and conjugated bilirubin, though commonly used interchangeably, are not identical, but for clinical purposes the terms may be used interchangeably 1

  • If total serum bilirubin is at or below 5 mg/dL (85 μmol/L), a direct or conjugated bilirubin of more than 1.0 mg/dL is considered abnormal 1

Important Clinical Caveats

  • Laboratory measurement of direct bilirubin is not precise, and values between laboratories can vary widely 1

  • A raised TBIL has been proposed to potentially alter biliary excretion of certain oncology compounds, resulting in clinical toxicity 1

  • When evaluating elevated total bilirubin, alternative causes must be investigated, including hemolysis, multiple transfusions, and other causes of unconjugated hyperbilirubinemia 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.